Complementary and Alternative Medicine-related Drug-induced Liver Injury in Asia
Open Access
- 2 September 2019
- journal article
- review article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. X (X), 1-12
- https://doi.org/10.14218/jcth.2019.00024
Abstract
The use of complementary and alternative medicines (CAMs) for treatment of acute and chronic diseases is on the rise world over, especially in Asian countries, and mostly in China and India. Drug-induced liver injury (DILI) due to CAM is increasingly reported in the literature from multiple centers all around the world and with large-number patient series published from the West, mostly based on nation-wide DILI networks and multicenter collaboration. Comprehensive DILI networks are lacking among major Asian countries with high incidence of CAM practices. Chinese medical societies dealing with drug toxicity, CAM practice and hepatobiliary disease have adopted an integrated approach to establishing identification, diagnosis and treatment of CAM-related DILI, representing a systematic approach that could be iterated by other countries for improving patient outcomes. In this exhaustive review, we provide published data on CAM-related DILI in Asia, with detail on incidences along with analysis of patient population and their clinical outcomes. Concise and clear discussion on commonly implicated CAM agents in major Asian countries and associated chemical and toxicology analyses as well as descriptions of liver biopsy findings are discussed with future directions.Keywords
This publication has 53 references indexed in Scilit:
- Causes and Outcomes of Acute Liver Failure in ChinaPLOS ONE, 2013
- Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and updateInternational Journal of Clinical Practice, 2012
- Hospital Admissions for Drug-Induced Liver Injury: Clinical Features, Therapy, and OutcomesCell Biochemistry and Biophysics, 2012
- Gotu Kola induced hepatotoxicity in a child—Need for caution with alternative remediesDigestive and Liver Disease, 2011
- Risk of Liver Injury Associated with Chinese Herbal Products Containing Radix bupleuri in 639,779 Patients with Hepatitis B Virus InfectionPLOS ONE, 2011
- A survey of the labeling information provided for ayurvedic drugs marketed in IndiaInternational Journal of Ayurveda Research, 2010
- Drug‐induced liver injury in Japan: An analysis of 1676 cases between 1997 and 2006Hepatology Research, 2009
- Predictors of Mortality in Hepatic Encephalopathy in Acute and Chronic Liver DiseaseJournal of Clinical Gastroenterology, 2007
- Drug‐induced liver injury at an Asian center: a prospective studyLiver International, 2007
- Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1‐year prospective studyAlimentary Pharmacology & Therapeutics, 2006